Ekso Bionics Holdings Inc.

1.7600.00Vol 44.83K1Y Perf -68.17%
May 18th, 2022 16:00 DELAYED
BID1.71 ASK1.83
Open1.83 Previous Close1.76
Pre-Market- After-Market1.82
 - -  0.06 3.41%
Target Price
11.00 
Analyst Rating
Strong Buy 1.00
Potential %
525.00 
Finscreener Ranking
★★★★+     56.61
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★★     55.41
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★     46.70
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
4.93 
Earnings Rating
Strong Sell
Market Cap22.61M 
Earnings Date
28th Apr 2022
Alpha-0.02 Standard Deviation0.35
Beta1.94 

Today's Price Range

1.761.83

52W Range

1.546.10

5 Year PE Ratio Range

-1.40-3.80

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
5.39%
1 Month
-30.16%
3 Months
-26.67%
6 Months
-49.57%
1 Year
-68.17%
3 Years
-93.41%
5 Years
-92.93%
10 Years
-

TickerPriceChg.Chg.%
EKSO1.760.00000.00
AAPL140.82-8.4200-5.64
GOOG2 248.02-86.0100-3.69
MSFT254.08-12.1200-4.55
XOM90.65-1.4600-1.59
WFC42.11-1.6000-3.66
JNJ175.50-3.3200-1.86
FB192.24-10.3800-5.12
GE75.20-1.2000-1.57
JPM120.09-2.0900-1.71
Financial StrengthValueIndustryS&P 500US Markets
6.60
7.20
0.06
0.06
-93.00
Leverage Ratio 1.30
ProfitabilityValueIndustryS&P 500US Markets
53.30
-89.10
-84.30
-194.00
-90.96
RevenueValueIndustryS&P 500US Markets
11.90M
0.93
-5.38
8.22
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.41-0.3612.20
Q04 2021-0.25-0.238.00
Q03 2021-0.25-0.1732.00
Q02 2021-0.25-0.26-4.00
Q01 2021-0.24-0.34-41.67
Q04 2020-0.30-0.48-60.00
Q03 2020-0.40-0.52-30.00
Q02 2020-0.51-0.510.00
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.247.69Positive
9/2022 QR-0.238.00Positive
12/2022 FY-1.000.99Positive
12/2023 FY-0.6320.25Positive
Next Report Date-
Estimated EPS Next Report-0.41
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume44.83K
Shares Outstanding12.84K
Shares Float12.77M
Trades Count211
Dollar Volume80.25K
Avg. Volume42.88K
Avg. Weekly Volume43.00K
Avg. Monthly Volume41.44K
Avg. Quarterly Volume44.20K

Ekso Bionics Holdings Inc. (NASDAQ: EKSO) stock closed at 1.76 per share at the end of the most recent trading day (a 1.73% change compared to the prior day closing price) with a volume of 14.41K shares and market capitalization of 22.61M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 68 people. Ekso Bionics Holdings Inc. CEO is Jack Peurach.

The one-year performance of Ekso Bionics Holdings Inc. stock is -68.17%, while year-to-date (YTD) performance is -33.58%. EKSO stock has a five-year performance of -92.93%. Its 52-week range is between 1.535 and 6.1, which gives EKSO stock a 52-week price range ratio of 4.93%

Ekso Bionics Holdings Inc. currently has a PE ratio of -1.90, a price-to-book (PB) ratio of 0.67, a price-to-sale (PS) ratio of 1.87, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -21.96%, a ROC of -26.41% and a ROE of -29.69%. The company’s profit margin is -90.96%, its EBITDA margin is -84.30%, and its revenue ttm is $11.90 Million , which makes it $0.93 revenue per share.

Of the last four earnings reports from Ekso Bionics Holdings Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.41 for the next earnings report. Ekso Bionics Holdings Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Ekso Bionics Holdings Inc. is Strong Buy (1), with a target price of $11, which is +525.00% compared to the current price. The earnings rating for Ekso Bionics Holdings Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Ekso Bionics Holdings Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Ekso Bionics Holdings Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 19.15, ATR14 : 0.15, CCI20 : -87.83, Chaikin Money Flow : -0.20, MACD : -0.25, Money Flow Index : 17.33, ROC : -22.47, RSI : 25.89, STOCH (14,3) : 22.84, STOCH RSI : 1.00, UO : 43.44, Williams %R : -77.16), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Ekso Bionics Holdings Inc. in the last 12-months were: Jason C. Jones (Sold 3 265 shares of value $9 206 ), John F. Glenn (Sold 3 462 shares of value $9 762 ), Scott G. Davis (Sold 4 043 shares of value $10 583 ), Steven Sherman (Option Excercise at a value of $0), Steven Sherman (Sold 5 965 shares of value $15 508 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Ekso Bionics Holdings Inc.

Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are EksoHealth and EksoWorks. All of the company's operations are held in the United States. The EksoHealth segment which derives majority revenue designs, engineers, manufactures and sells exoskeletons for applications in the medical markets.

CEO: Jack Peurach

Telephone: +1 510 984-1761

Address: 1414 Harbour Way South, Richmond 94804, CA, US

Number of employees: 68

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

54%46%

Bearish Bullish

50%50%

TipRanks News for EKSO

Fri, 29 Apr 2022 10:25 GMT Analysts Offer Insights on Healthcare Companies: Seagen (SGEN), EKSO BIONICS (EKSO) and Zynex (ZYXI)

- TipRanks. All rights reserved.

Mon, 28 Feb 2022 11:16 GMT EKSO BIONICS (EKSO) Gets a Buy Rating from H.C. Wainwright

- TipRanks. All rights reserved.

News

Stocktwits